The Evolution of Lung Cancer Therapies at a Glance
By Ruchi Jhonsa, Ph.D. In 1910, esteemed surgeon Alton Ochsner recalled, “As a student, I was asked to witness an autopsy of a patient with lung cancer because I was …
Read MoreThe Next Generation Biotech Media
By Ruchi Jhonsa, Ph.D. In 1910, esteemed surgeon Alton Ochsner recalled, “As a student, I was asked to witness an autopsy of a patient with lung cancer because I was …
Read MoreRecently, the USFDA approved phase 3 trials to evaluate the repurposed rheumatoid arthritis drug, Actemra in treating adult patients with severe COVID-19 pneumonia. Roche’s strategic partner, Chugai now follows suit …
Read MoreBy Ruchi Jhonsa, Ph.D. Arrakis Therapeutics, a startup aimed at targeting RNA announced a strategic collaboration and license deal with Roche to explore new drug candidates for Roche’s existing research …
Read MoreBy Rajaneesh K. Gopinath, Ph.D. A new study conducted by researchers from Roche find that dendritic cells are key targets of immune checkpoint inhibitors and their abundance might determine patient …
Read MoreBy Ruchi Jhonsa, Ph.D. Edited by Rajaneesh K. Gopinath, Ph.D. When Thermo Fisher Scientific announced its agreement to buy Qiagen earlier this month, analysts suggested that Thermo intends to expand …
Read MoreBy Ruchi Jhonsa, Ph.D. In the current situation, where coronavirus is spreading at a rapid rate, it is crucial to speed up the diagnosis. Looking at the growing numbers, the …
Read MoreBy Ruchi Jhonsa, Ph.D. Diagnosing a disease early on can be a challenge especially when the tools for detection are insensitive. This challenge is regularly faced in diagnosing liver cancer …
Read MoreOxford-based company Exscientia has collaborated with Sumitomo Dainippon Pharma in developing drugs using Artificial Intelligence (AI) technology. DSP-1181, the first drug designed by AI, aims to treat obsessive-compulsive disorder and …
Read MoreBy Sahana Shankar In another step towards fighting relapsed Diffuse Large B-Cell Lymphoma (DLBCL), a type of blood cancer, Roche scores EU approval for its novel combination therapy. Roche announces …
Read More2019 was a year replete with major pharma, biotech, and digital healthcare deals. Here we highlight some of the major mergers and acquisitions of the year. 1. Bristol-Myers Squibb Acquires …
Read More